CCL5 and hepatocellular carcinoma: Additionally, it has been shown that overexpression of CCL5 can induce an immune response against tumors and counteract immune evasion in β‐catenin‐driven mouse HCC.[16] Hence, the potential role of CCL5 in HCC treatment is a promising avenue and warrants further investigation.